Progression to impaired glucose regulation, diabetes and metabolic syndrome in Chinese women with a past history of gestational diabetes

Diabetes/Metabolism Research and Reviews

Volumn 23, Issue 6, 2007, Pages 485-489

  Tam, Wing Hung ^a   Yang, Xi Lin ^a   Chan, Juliana C N ^a   Ko, Gary T C ^b   Tong, Peter C Y ^a   Ma, Ronald C W ^a   Cockram, Clive S ^a   Sahota, Daljit ^a   Rogers, Michael S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b ALICE HO MIU LING NETHERSOLE HOSPITAL   (Hong Kong)

Author keywords

Chinese; Diabetes; Gestational diabetes mellitus; Impaired glucose regulation; Metabolic syndrome

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; BODY MASS; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FAMILY HISTORY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS; DIABETES, GESTATIONAL; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HUMANS; MEDICAL RECORDS; METABOLIC SYNDROME X; OVERWEIGHT; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 34948869812     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.741     Document Type: Article

References (34)

1. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14(Suppl. 5): S1-S85.
2. Bartnik M, Ryden L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25: 1880-1890.
3. Harris R, Donahue K, Rathore SS, Frame P, Woolf SH, Lohr KN. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003; 138: 215-229.
4. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention. The cost-effectiveness of screening for type 2 diabetes. JAMA 1998; 280: 1757-1763.
5. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. WHO: Geneva, 1999.
6. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002; 25: 1862-1868.
7. Cheung NW, Byth K. Population health significance of gestational diabetes. Diabetes Care 2003; 26: 2005-2009.
8. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28: 1769-1778.
9. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428.
10. Lauenborg J, Mathiesen E, Hansen T, et al. The prevalence of the metabolic syndrome in a danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab 2005; 90: 4004-4010.
11. Albareda M, Caballero A, Badell G, et al. Metabolic syndrome at follow-up in women with and without gestational diabetes mellitus in index pregnancy. Metabolism 2005; 54: 1115-1121.
12. Ko GT, Chan JC, Tsang LW, Li CY, Cockram CS. Glucose intolerance and other cardiovascular risk factors in chinese women with a history of gestational diabetes mellitus. Aust N Z J Obstet Gynaecol 1999; 39: 478-483.
13. Ko GT, Tam WH, Chan JC, Rogers M. Prevalence of gestational diabetes mellitus in Hong Kong based on the 1998 WHO criteria. Diabet Med 2002; 19: 80.
14. Gu D, Reynolds K, Duan X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003; 46: 1190-1198.
15. Tam WH, Rogers MS, Yip SK, Lau TK, Leung TY. Which screening test is the best for gestational impaired glucose tolerance and gestational diabetes mellitus? Diabetes Care 2000; 23: 1432.
16. World Health Organization. The Asian-Pacific Perspective: Redefining Obesity and its Treatment. World Health Organization, Western Pacific Region: Geneva, 2000.
17. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29(Suppl. 1): S43-S48.
18. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-1062.
19. Wat NM, Lam TH, Janus ED, Lam KS. Central obesity predicts the worsening of glycemia in southern Chinese. Int J Obes Relat Metab Disord 2001; 25: 1789-1793.
20. Ko GT, Li JK, Cheung AY, et al. Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese. Diabetes Care 1999; 22: 2096-2097.
21. Ko GT, Chan JC, Tsang LW, Yeung VT, Chow CC, Cockram CS. Outcomes of screening for diabetes in high-risk Hong Kong Chinese subjects. Diabetes Care 2000; 23: 1290-1294.
22. Ko GT, Chan JC, Tsang LW, Cockram CS. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. Diabetes Care 2000; 23: 1770-1773.
23. Thomas GN, Ho SY, Janus ED, Lam KS, Hedley AJ, Lam TH. The US National cholesterol education programme adult treatment panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract 2005; 67: 251-257.
24. Chen KT, Chen CJ, Gregg EW, Imperatore G, Narayan KM. Impaired fasting glucose and risk of diabetes in Taiwan: follow-up over 3 years. Diabetes Res Clin Pract 2003; 60: 177-182.
25. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore longitudinal study of aging. Diabetes 2003; 52: 1475-1484.
26. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006; 49: 289-297.
27. Ng MC, Li JK, So WY, et al. Nature or nurture: an insightful illustration from a Chinese family with hepatocyte nuclear factor-1 alpha diabetes (MODY3). Diabetologia 2000; 43: 816-818.
28. Albareda M, Caballero A, Badell G, et al. Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 2003; 26: 1199-1205.
29. Dalfra MG, Lapolla A, Masin M, et al. Antepartum and early postpartum predictors of type 2 diabetes development in women with gestational diabetes mellitus. Diabetes Metab 2001; 27: 675-680.
30. Henry OA, Beischer NA. Long-term implications of gestational diabetes for the mother. Baillieres Clin Obstet Gynaecol 1991; 5: 461-483.
31. Aberg AE, Jonsson EK, Eskilsson I, Landin-Olsson M, Frid AH. Predictive factors of developing diabetes mellitus in women with gestational diabetes. Acta Obstet Gynecol Scand 2002; 81: 11-16.
32. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM trial data. Diabetologia 2004; 47: 969-975.
33. Snitker S, Watanabe RM, Ani I, et al. Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabetes (TRIPOD) study. Diabetes Care 2004; 27: 1365-1368.
34. Heymsfield SB, Segal KR, Hauptman J, et al. Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch Intern Med 2000; 160: 1321-1326.